Identification of gene expression profiles and immune cell infiltration signatures between low and high tumor mutation burden groups in bladder cancer

Bladder cancer is one of the most commonly diagnosed tumors and is results from the accumulation of somatic mutations in the DNA. Tumor mutation burden (TMB) has been associated with cancer immunotherapeutic response. In this study, we attempted to explore the correlation between TMB and cancer prog...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of medical sciences 2020, Vol.17 (1), p.89-96
Hauptverfasser: Wu, Zonglong, Wang, Muru, Liu, Qinggang, Liu, Yaxiao, Zhu, Kejia, Chen, Lipeng, Guo, Hongda, Li, Yan, Shi, Benkang
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 96
container_issue 1
container_start_page 89
container_title International journal of medical sciences
container_volume 17
creator Wu, Zonglong
Wang, Muru
Liu, Qinggang
Liu, Yaxiao
Zhu, Kejia
Chen, Lipeng
Guo, Hongda
Li, Yan
Shi, Benkang
description Bladder cancer is one of the most commonly diagnosed tumors and is results from the accumulation of somatic mutations in the DNA. Tumor mutation burden (TMB) has been associated with cancer immunotherapeutic response. In this study, we attempted to explore the correlation between TMB and cancer prognosis. Identify the different expressed genes and immune cell infiltration signatures between low and high TMB group. Mutation data, gene expression profiles and clinical data were downloaded from The Cancer Genome Atlas (TCGA) database. Patients were divided into high and low TMB groups, allowing differentially expressed genes (DEGs) to be identified. Functional enrichment and protein-protein interaction (PPI) network analysis were used to identify the functions of the DEGs. And immune cell infiltration signatures were evaluated by CIBERSORT algorithm. These results shown that high TMB was significantly associated with prognosis. We obtained a list of TMB related genes which may influence the infiltrations of immune cells. We also found a higher proportion of CD8 T cells, CD4 T cells and NK cells in the high TMB group. Our data suggest that higher TMB tends to promote the infiltrations of T cells and NK cells and patients with higher TMB may achieve a more favorable prognosis in bladder cancer.
doi_str_mv 10.7150/ijms.39056
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6945555</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2338090922</sourcerecordid><originalsourceid>FETCH-LOGICAL-c406t-7f0bf7e93262b47d79ec3c405de21de42be43ce9ad9208edd2278a53f1f539123</originalsourceid><addsrcrecordid>eNpdUUtrFTEUHsRia3XjD5CAGxFuzWsmNxtBio9CoZu6DpnkZG4uM8mYTFr9I_5eM7211GaTcL7HOTlf07wh-EyQFn_0-ymfMYnb7llzQjiXGyKxeP7ofdy8zHmPMaNMkBfNMSOSSsHpSfPnwkJYvPNGLz4GFB0aIACCX3OCnNfSnKLzI2Skg0V-mkqFDYwj8qHWl3QQZj8EvZQqQj0stwABjfH2TrPzww4tZYoJTWU50PuSamM0pFjmXJ1QP2prISGjg4H0qjlyeszw-v4-bX58_XJ9_n1zefXt4vzz5cZw3C0b4XDvBEhGO9pzYYUEwyrUWqDEAqc9cGZAaisp3oK1lIqtbpkjrmWSUHbafDr4zqWfwJq6i6RHNSc_6fRbRe3V_0jwOzXEG9VJ3tZTDd7fG6T4s0Be1OTzuh0dIJasKGNbLLGka693T6j7WFKo31O0lVsqedfxyvpwYJkUc07gHoYhWK1xqzVudRd3Jb99PP4D9V--7C_LCKr5</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2598294664</pqid></control><display><type>article</type><title>Identification of gene expression profiles and immune cell infiltration signatures between low and high tumor mutation burden groups in bladder cancer</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>PubMed Central Open Access</source><creator>Wu, Zonglong ; Wang, Muru ; Liu, Qinggang ; Liu, Yaxiao ; Zhu, Kejia ; Chen, Lipeng ; Guo, Hongda ; Li, Yan ; Shi, Benkang</creator><creatorcontrib>Wu, Zonglong ; Wang, Muru ; Liu, Qinggang ; Liu, Yaxiao ; Zhu, Kejia ; Chen, Lipeng ; Guo, Hongda ; Li, Yan ; Shi, Benkang</creatorcontrib><description>Bladder cancer is one of the most commonly diagnosed tumors and is results from the accumulation of somatic mutations in the DNA. Tumor mutation burden (TMB) has been associated with cancer immunotherapeutic response. In this study, we attempted to explore the correlation between TMB and cancer prognosis. Identify the different expressed genes and immune cell infiltration signatures between low and high TMB group. Mutation data, gene expression profiles and clinical data were downloaded from The Cancer Genome Atlas (TCGA) database. Patients were divided into high and low TMB groups, allowing differentially expressed genes (DEGs) to be identified. Functional enrichment and protein-protein interaction (PPI) network analysis were used to identify the functions of the DEGs. And immune cell infiltration signatures were evaluated by CIBERSORT algorithm. These results shown that high TMB was significantly associated with prognosis. We obtained a list of TMB related genes which may influence the infiltrations of immune cells. We also found a higher proportion of CD8 T cells, CD4 T cells and NK cells in the high TMB group. Our data suggest that higher TMB tends to promote the infiltrations of T cells and NK cells and patients with higher TMB may achieve a more favorable prognosis in bladder cancer.</description><identifier>ISSN: 1449-1907</identifier><identifier>EISSN: 1449-1907</identifier><identifier>DOI: 10.7150/ijms.39056</identifier><identifier>PMID: 31929742</identifier><language>eng</language><publisher>Australia: Ivyspring International Publisher Pty Ltd</publisher><subject>Antigens ; Apoptosis ; Bladder cancer ; Chemokines ; Extracellular matrix ; Gene expression ; Genomes ; Immunotherapy ; Medical prognosis ; Mutation ; Proteins ; Research Paper ; Software ; Survival analysis ; T cell receptors ; Tumors</subject><ispartof>International journal of medical sciences, 2020, Vol.17 (1), p.89-96</ispartof><rights>The author(s).</rights><rights>2020. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>The author(s) 2020</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c406t-7f0bf7e93262b47d79ec3c405de21de42be43ce9ad9208edd2278a53f1f539123</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6945555/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6945555/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,4010,27902,27903,27904,53769,53771</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31929742$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wu, Zonglong</creatorcontrib><creatorcontrib>Wang, Muru</creatorcontrib><creatorcontrib>Liu, Qinggang</creatorcontrib><creatorcontrib>Liu, Yaxiao</creatorcontrib><creatorcontrib>Zhu, Kejia</creatorcontrib><creatorcontrib>Chen, Lipeng</creatorcontrib><creatorcontrib>Guo, Hongda</creatorcontrib><creatorcontrib>Li, Yan</creatorcontrib><creatorcontrib>Shi, Benkang</creatorcontrib><title>Identification of gene expression profiles and immune cell infiltration signatures between low and high tumor mutation burden groups in bladder cancer</title><title>International journal of medical sciences</title><addtitle>Int J Med Sci</addtitle><description>Bladder cancer is one of the most commonly diagnosed tumors and is results from the accumulation of somatic mutations in the DNA. Tumor mutation burden (TMB) has been associated with cancer immunotherapeutic response. In this study, we attempted to explore the correlation between TMB and cancer prognosis. Identify the different expressed genes and immune cell infiltration signatures between low and high TMB group. Mutation data, gene expression profiles and clinical data were downloaded from The Cancer Genome Atlas (TCGA) database. Patients were divided into high and low TMB groups, allowing differentially expressed genes (DEGs) to be identified. Functional enrichment and protein-protein interaction (PPI) network analysis were used to identify the functions of the DEGs. And immune cell infiltration signatures were evaluated by CIBERSORT algorithm. These results shown that high TMB was significantly associated with prognosis. We obtained a list of TMB related genes which may influence the infiltrations of immune cells. We also found a higher proportion of CD8 T cells, CD4 T cells and NK cells in the high TMB group. Our data suggest that higher TMB tends to promote the infiltrations of T cells and NK cells and patients with higher TMB may achieve a more favorable prognosis in bladder cancer.</description><subject>Antigens</subject><subject>Apoptosis</subject><subject>Bladder cancer</subject><subject>Chemokines</subject><subject>Extracellular matrix</subject><subject>Gene expression</subject><subject>Genomes</subject><subject>Immunotherapy</subject><subject>Medical prognosis</subject><subject>Mutation</subject><subject>Proteins</subject><subject>Research Paper</subject><subject>Software</subject><subject>Survival analysis</subject><subject>T cell receptors</subject><subject>Tumors</subject><issn>1449-1907</issn><issn>1449-1907</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><recordid>eNpdUUtrFTEUHsRia3XjD5CAGxFuzWsmNxtBio9CoZu6DpnkZG4uM8mYTFr9I_5eM7211GaTcL7HOTlf07wh-EyQFn_0-ymfMYnb7llzQjiXGyKxeP7ofdy8zHmPMaNMkBfNMSOSSsHpSfPnwkJYvPNGLz4GFB0aIACCX3OCnNfSnKLzI2Skg0V-mkqFDYwj8qHWl3QQZj8EvZQqQj0stwABjfH2TrPzww4tZYoJTWU50PuSamM0pFjmXJ1QP2prISGjg4H0qjlyeszw-v4-bX58_XJ9_n1zefXt4vzz5cZw3C0b4XDvBEhGO9pzYYUEwyrUWqDEAqc9cGZAaisp3oK1lIqtbpkjrmWSUHbafDr4zqWfwJq6i6RHNSc_6fRbRe3V_0jwOzXEG9VJ3tZTDd7fG6T4s0Be1OTzuh0dIJasKGNbLLGka693T6j7WFKo31O0lVsqedfxyvpwYJkUc07gHoYhWK1xqzVudRd3Jb99PP4D9V--7C_LCKr5</recordid><startdate>2020</startdate><enddate>2020</enddate><creator>Wu, Zonglong</creator><creator>Wang, Muru</creator><creator>Liu, Qinggang</creator><creator>Liu, Yaxiao</creator><creator>Zhu, Kejia</creator><creator>Chen, Lipeng</creator><creator>Guo, Hongda</creator><creator>Li, Yan</creator><creator>Shi, Benkang</creator><general>Ivyspring International Publisher Pty Ltd</general><general>Ivyspring International Publisher</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>2020</creationdate><title>Identification of gene expression profiles and immune cell infiltration signatures between low and high tumor mutation burden groups in bladder cancer</title><author>Wu, Zonglong ; Wang, Muru ; Liu, Qinggang ; Liu, Yaxiao ; Zhu, Kejia ; Chen, Lipeng ; Guo, Hongda ; Li, Yan ; Shi, Benkang</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c406t-7f0bf7e93262b47d79ec3c405de21de42be43ce9ad9208edd2278a53f1f539123</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Antigens</topic><topic>Apoptosis</topic><topic>Bladder cancer</topic><topic>Chemokines</topic><topic>Extracellular matrix</topic><topic>Gene expression</topic><topic>Genomes</topic><topic>Immunotherapy</topic><topic>Medical prognosis</topic><topic>Mutation</topic><topic>Proteins</topic><topic>Research Paper</topic><topic>Software</topic><topic>Survival analysis</topic><topic>T cell receptors</topic><topic>Tumors</topic><toplevel>online_resources</toplevel><creatorcontrib>Wu, Zonglong</creatorcontrib><creatorcontrib>Wang, Muru</creatorcontrib><creatorcontrib>Liu, Qinggang</creatorcontrib><creatorcontrib>Liu, Yaxiao</creatorcontrib><creatorcontrib>Zhu, Kejia</creatorcontrib><creatorcontrib>Chen, Lipeng</creatorcontrib><creatorcontrib>Guo, Hongda</creatorcontrib><creatorcontrib>Li, Yan</creatorcontrib><creatorcontrib>Shi, Benkang</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>International journal of medical sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wu, Zonglong</au><au>Wang, Muru</au><au>Liu, Qinggang</au><au>Liu, Yaxiao</au><au>Zhu, Kejia</au><au>Chen, Lipeng</au><au>Guo, Hongda</au><au>Li, Yan</au><au>Shi, Benkang</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Identification of gene expression profiles and immune cell infiltration signatures between low and high tumor mutation burden groups in bladder cancer</atitle><jtitle>International journal of medical sciences</jtitle><addtitle>Int J Med Sci</addtitle><date>2020</date><risdate>2020</risdate><volume>17</volume><issue>1</issue><spage>89</spage><epage>96</epage><pages>89-96</pages><issn>1449-1907</issn><eissn>1449-1907</eissn><abstract>Bladder cancer is one of the most commonly diagnosed tumors and is results from the accumulation of somatic mutations in the DNA. Tumor mutation burden (TMB) has been associated with cancer immunotherapeutic response. In this study, we attempted to explore the correlation between TMB and cancer prognosis. Identify the different expressed genes and immune cell infiltration signatures between low and high TMB group. Mutation data, gene expression profiles and clinical data were downloaded from The Cancer Genome Atlas (TCGA) database. Patients were divided into high and low TMB groups, allowing differentially expressed genes (DEGs) to be identified. Functional enrichment and protein-protein interaction (PPI) network analysis were used to identify the functions of the DEGs. And immune cell infiltration signatures were evaluated by CIBERSORT algorithm. These results shown that high TMB was significantly associated with prognosis. We obtained a list of TMB related genes which may influence the infiltrations of immune cells. We also found a higher proportion of CD8 T cells, CD4 T cells and NK cells in the high TMB group. Our data suggest that higher TMB tends to promote the infiltrations of T cells and NK cells and patients with higher TMB may achieve a more favorable prognosis in bladder cancer.</abstract><cop>Australia</cop><pub>Ivyspring International Publisher Pty Ltd</pub><pmid>31929742</pmid><doi>10.7150/ijms.39056</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1449-1907
ispartof International journal of medical sciences, 2020, Vol.17 (1), p.89-96
issn 1449-1907
1449-1907
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6945555
source Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; PubMed Central Open Access
subjects Antigens
Apoptosis
Bladder cancer
Chemokines
Extracellular matrix
Gene expression
Genomes
Immunotherapy
Medical prognosis
Mutation
Proteins
Research Paper
Software
Survival analysis
T cell receptors
Tumors
title Identification of gene expression profiles and immune cell infiltration signatures between low and high tumor mutation burden groups in bladder cancer
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T05%3A13%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Identification%20of%20gene%20expression%20profiles%20and%20immune%20cell%20infiltration%20signatures%20between%20low%20and%20high%20tumor%20mutation%20burden%20groups%20in%20bladder%20cancer&rft.jtitle=International%20journal%20of%20medical%20sciences&rft.au=Wu,%20Zonglong&rft.date=2020&rft.volume=17&rft.issue=1&rft.spage=89&rft.epage=96&rft.pages=89-96&rft.issn=1449-1907&rft.eissn=1449-1907&rft_id=info:doi/10.7150/ijms.39056&rft_dat=%3Cproquest_pubme%3E2338090922%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2598294664&rft_id=info:pmid/31929742&rfr_iscdi=true